CN Bio Innovations
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
332 Cambridge Science Park Milton Rd, Ca...Phone Number
+44 1223737941Website
www.cn-bio.comRevenue
$12.2 MillionIndustry
About CN Bio Innovations
CN Bio Innovations Org Chart
Is CN Bio Innovations your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on CN Bio Innovations recently announced quarterly report
Funding: Get notified immidiatlly once CN Bio Innovations has new funding data
Congratulate Masked Content for being promoted to Masked Content at CN Bio Innovations
CN Bio Innovations, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when CN Bio Innovations launches new products
Click to see if CN Bio Innovations had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if CN Bio Innovations is spiking on competitors!
Check if CN Bio Innovations has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at CN Bio Innovations
Find more new buyers
Compare Similar Companies to CN Bio Innovations
Compare insights from companies similar to CN Bio Innovations, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CN Bio Innovations is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CN Bio Innovations is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CN Bio Innovations.
CN Bio Innovations financials insights
Gather financial insights about CN Bio Innovations, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Other Financing Round
$21M
CN Bio Innovations Tech Stack
A closer look at the technologies used by CN Bio Innovations
Most Recent Scoops
CN Bio Innovations News & Media
CN Bio introduces cross-species DILI services to enhance in vitro to in vivo extrapolation during preclinical drug development
CAMBRIDGE, England--(BUSINESS WIRE)--CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, has introduced two new animal microphysiological system (MPS) models that enhance translatability in preclinical drug safety and toxicology assessments to its Contract Research Services (CRS). Building upon the Company’s FDA-recognized drug induced liver injury (DILI) assay, the expanded offering enables rapid, comparative studiCN Bio and Pharmaron establish long-term partnership - European Pharmaceutical Manufacturer
CN Bio, a provider of Organ-on-a-chip systems and solutions that accelerate drug discovery and development workflows, has announced the establishment of a strategic partnership with Pharmaron, a premier R&D service provider for the industry.CN Bio and Pharmaron Establish Long-Term Strategic Partnership to Develop OOC Technologies on a Global R&D Platform
CAMBRIDGE, England--(BUSINESS WIRE)--CN Bio, a leading provider of Organ-on-a-chip systems and solutions that accelerate drug discovery and development workflows, today announced the establishment of a strategic partnership with Pharmaron, a premier R&D service provider for the life sciences industry. Under the agreement, Pharmaron will validate CN Bio’s PhysioMimix® technology across existing applications and collaborate on integrating OOC technologies into its R&D platform. The partneCN Bio Launches PhysioMimix DILI Assay Kit: Human 24, for Enhanced Preclinical Toxicology Testing
CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix® DILI assay kit: Human 24. Built upon CN Bio’s human-derived and highly characterized liver microphysiological system (MPS), the DILI assay kit provides robust, human-relevant insights into crucial drug safety parameters, to support more informed clinical progression of drug c
Top Business Services Companies
Frequently Asked Questions Regarding CN Bio Innovations
CN Bio is a leading Organ-on-a-chip company that specializes in transforming drug discovery through its innovative PhysioMimix Core predictive human organ models and assays. Their product offerings include a range of microphysiological systems, consumables, and organ-on-a-chip models designed to accurately predict human drug responses. The company... Read More